I reported previously (July 2016) that the minimally invasive RENOVA leg implant from Israel’s BlueWind to treat Overactive Bladder (OAB) had been granted European approval. Recent trials show that device gave over 50% improvement to 71% of participants.
Successful trials of implant to prevent OAB
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.